BioCryst Pharmaceuticals, Inc. financials

   Watch this stock
In Millions of USD (except for per share items) 3 months ending 2013-03-31 3 months ending 2012-12-31 3 months ending 2012-09-30 3 months ending 2012-06-30 3 months ending 2012-03-31
Revenue 3.55 4.10 5.76 4.21 12.22
Other Revenue, Total - - - - -
Total Revenue 3.55 4.10 5.76 4.21 12.22
Cost of Revenue, Total 0.08 0.02 0.11 - 0.00
Gross Profit 3.48 4.08 5.65 4.21 12.22
Selling/General/Admin. Expenses, Total 1.38 1.93 1.59 1.61 1.70
Research & Development 7.41 11.09 12.07 12.78 15.53
Depreciation/Amortization - - - - -
Interest Expense(Income) - Net Operating - - - - -
Unusual Expense (Income) - 1.76 - - -
Other Operating Expenses, Total - - - - -
Total Operating Expense 8.87 14.80 13.78 14.39 17.22
Operating Income -5.32 -10.70 -8.02 -10.18 -5.00
Interest Income(Expense), Net Non-Operating - - - - -
Gain (Loss) on Sale of Assets - - - - -
Other, Net - - - - -
Income Before Tax -4.51 -11.05 -9.70 -12.28 -6.05
Income After Tax -4.51 -11.05 -9.70 -12.28 -6.05
Minority Interest - - - - -
Equity In Affiliates - - - - -
Net Income Before Extra. Items -4.51 -11.05 -9.70 -12.28 -6.05
Accounting Change - - - - -
Discontinued Operations - - - - -
Extraordinary Item - - - - -
Net Income -4.51 -11.05 -9.70 -12.28 -6.05
Preferred Dividends - - - - -
Income Available to Common Excl. Extra Items -4.51 -11.05 -9.70 -12.28 -6.05
Income Available to Common Incl. Extra Items -4.51 -11.05 -9.70 -12.28 -6.05
Basic Weighted Average Shares - - - - -
Basic EPS Excluding Extraordinary Items - - - - -
Basic EPS Including Extraordinary Items - - - - -
Dilution Adjustment 0.00 0.00 0.00 0.00 0.00
Diluted Weighted Average Shares 51.07 50.88 50.66 49.22 47.10
Diluted EPS Excluding Extraordinary Items -0.09 -0.22 -0.19 -0.25 -0.13
Diluted EPS Including Extraordinary Items - - - - -
Dividends per Share - Common Stock Primary Issue 0.00 0.00 0.00 0.00 0.00
Gross Dividends - Common Stock - - - - -
Net Income after Stock Based Comp. Expense - - - - -
Basic EPS after Stock Based Comp. Expense - - - - -
Diluted EPS after Stock Based Comp. Expense - - - - -
Depreciation, Supplemental - - - - -
Total Special Items - - - - -
Normalized Income Before Taxes - - - - -
Effect of Special Items on Income Taxes - - - - -
Income Taxes Ex. Impact of Special Items - - - - -
Normalized Income After Taxes - - - - -
Normalized Income Avail to Common - - - - -
Basic Normalized EPS - - - - -
Diluted Normalized EPS -0.09 -0.18 -0.19 -0.25 -0.13